EDI OCT evaluation of choroidal thickness in Stargardt disease

نویسندگان

  • Andrea Sodi
  • Daniela Bacherini
  • Chiara Lenzetti
  • Orsola Caporossi
  • Vittoria Murro
  • Dario Pasquale Mucciolo
  • Francesca Cipollini
  • Ilaria Passerini
  • Gianni Virgili
  • Stanislao Rizzo
چکیده

PURPOSE Choroidal thickness (CT) evaluation with EDI-OCT in Stargardt Disease (STGD), considering its possible association with some clinical features of the disease. METHODS CT was evaluated in 41 STGD patients and in 70 controls. Measurements were performed in the subfoveal position and at 1000 μm nasally and temporally. CT average values in STGD and in the control group were first compared by means of Student's T test. Then, the possible association between CT and some clinical features was evaluated by means of linear regression analysis. Considered clinical parameters were: age, age on onset, duration of the disease, visual acuity, foveal thickness, Fishman clinical phenotype, visual field loss and ERG response. RESULTS Average CT was not significantly different between controls and STGD patients. In the STGD group the correlation between CT and age (r = 0.22, p = 0.033) and age of onset (r = 0.05, p = 0.424) was modest, while that of CT with disease duration (r = 0.30, p<0.001) was moderate. CT and foveal thickness were also significantly but modestly correlated (r = 0.15, p = 0.033). CONCLUSION In our series average CT is not significantly changed in STGD in comparison with the controls. Nevertheless a choroidal thinning may be identified in the more advanced stages of the disease.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluation of Normal Choroidal Thickness in Rasht Using SD-OCT EDI Imaging

Purpose: To measure choroidal thickness in normal subjects, using optical coherent tomography (OCT) in Rasht. Methods: Normal subjects older than 20 years, living in Rasht, were selected through systematic random sampling by using the city telephone directory. The subjects underwent comprehensive eye examinations for inclusion in the study. Then, choroidal thickness was measured in both eyes by...

متن کامل

Choroidal hyperreflective foci in Stargardt disease shown by spectral-domain optical coherence tomography imaging: correlation with disease severity.

IMPORTANCE The presence of choroidal hyperreflective foci in Stargardt disease is, to our knowledge, a potentially new finding. Evaluation of these foci may aid in better understanding of the disease process. OBJECTIVES To report the presence of choroidal hyperreflective foci in spectral-domain optical coherence tomography (SD-OCT) images from eyes with Stargardt disease and investigate the r...

متن کامل

Enhanced Depth Imaging Optical Coherence Tomography A New Method in Diagnosis and Evaluation of Treatment for Choroidal Hemangioma: A Case Report

Purpose: To report the evaluation of the treatment response in choroidal hemangioma with application of enhanced depth imaging optical coherence tomography (EDI-OCT) technique Case report: A 73-year-old woman with a circumscribed choroidal hemangioma in the posterior pole of her left eye underwent photodynamic therapy and intravitreal injection of bevacizumab. EDI-OCT obtained from the affected...

متن کامل

Retinal and Choroidal Imaging With 870-nm Spectral-Domain OCT Compared With 1050-nm Spectral-Domain OCT, With and Without Enhanced Depth Imaging.

PURPOSE The purpose of this study was to compare images of the retina and choroid obtained with Spectralis 1050-nm spectral-domain optical coherence tomography (SD-OCT) with and without enhanced depth imaging (EDI) to the commercially available 870-nm SD-OCT with and without EDI. METHODS Full-length 30° line scans were obtained with both 870- and 1050-nm Spectralis OCT instruments, with and w...

متن کامل

Baseline subfoveal choroidal thickness as an indicator for bevacizumab outcomes in central retinal vein occlusion

Background: Retinal vein occlusions are one of the most common form of retinal vascular disorders and could lead to vision loss due to macular edema, macular ischemia and sequelae from neovascularization. Anti-venous endothelial growth factor (anti-VEGF) treatment is the choice strategy of treatment for patients with macular edema secondary to central retinal vein occlusion (CRVO). There is an ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 13  شماره 

صفحات  -

تاریخ انتشار 2018